Vivek Ramaswamy, a wealthy biotech entrepreneur and investor and the author of “Woke, Inc.,” has entered the Republican race for president.
The biotech entrepreneur hopes to avoid the most common fate of self-funded candidates. Vivek Ramaswamy, then the founder and CEO of Roivant Sciences, speaks at the Forbes Under 30 Summit in 2015. The biggest source of wealth for Ramaswamy is equity in companies he has founded. | Lisa Lake...
Myovant, the biggest biotech IPO in 2016, did better. Two drugs that it had purchased from Takeda won FDA approval. The company is valued at $1.6bn, although shares are down nearly 40 per cent from their 2020 peak. While running Roivant, Ramaswamy signed a 2017open letterin which biotech...
Ramaswamy, who built a biotech company that’s currently valued at $7 billion, treats running for president like it’s a startup. Currently in fifth place in the Republican field, he makes up for it by being, well, inescapable. Williamson and Kennedy may have fewer on their respective...
Vivek Ramaswamy got a lot of early attention as a US presidential candidate. But the biotech tycoon-turned-culture warrior could not turn the buzz into enough primary votes. Now he has moved on to activist investing, targeting another one-time high flyer struggling to live up to the hype: ...
Vivek Ramaswamy (born 1985) is an American biotech entrepreneur who drew national attention with his bid for the Republican nomination in the 2024 U.S. presidential election.
Vivek Ramaswamy, the 37-year-oldfame-seekingbiotech entrepreneur who honed his populist culture-warrior persona on Fox’s airwaves, hassurged in recent pollsand is suddenly vying with DeSantis for second place. It appears the conservative cable giant smells the desperation from DeSantis’ camp—app...